625
Participants
Start Date
December 31, 2022
Primary Completion Date
December 31, 2023
Study Completion Date
June 30, 2024
rK28
"rK28 RDT (Index): The Leishmania Ab Rapid Test is a rapid immunochromatographic test that uses the recombinant antigen rK28 to detect antibodies against Leishmania species in human serum, plasma, or whole blood samples intended for primary VL diagnosis. It is a Research Use Only product commercialized by CTK Biotech, Inc. (USA).~IT-Leish rK39 RDT: Rapid immunochromatographic test for detection of antibodies against Leishmania species in human serum, plasma, or whole blood samples of utility in the VL diagnosis algorithm. It is a CE marked product commercialized by Bio-Rad (France). This is currently the recommended RDT for VL diagnosis in Kenya.~Kalazar Detect rK39, RDT: Rapid immunochromatographic test for detection of antibodies against Leishmania species in human serum, plasma, or whole blood samples of utility in the VL diagnosis algorithm. It is a CE marked product commercialized by InBios (United States)."
RECRUITING
Turkana County, Lodwar
RECRUITING
Marsabit County, Marsabit
ACTIVE_NOT_RECRUITING
Kenya Medical Research Institute, Nairobi
RECRUITING
Wajir County, Wajir
Collaborators (1)
Kenya Medical Research Institute
OTHER
Foundation for Innovative New Diagnostics, Switzerland
OTHER